HeartFlow Announces JAMA Publication and Presentation of Landmark Data Showing High Diagnostic Performance for Non-Invasive Fractional Flow Reserve (FFRCT) Technology

REDWOOD CITY, Calif. & MUNICH--(BUSINESS WIRE)--HeartFlow, Inc. announced today that data from the company’s landmark prospective, international Determination of Fractional Flow Reserve by Anatomic Computed Tomographic Angiography (DeFACTO) study was presented today by principal investigator James K. Min, M.D., director of Cardiac Imaging Research at the Department of Medicine, Imaging and Biomedical Sciences at Cedars-Sinai Medical Center in Los Angeles, in a hotline session at the European Society of Cardiology (ESC) meeting in Munich, and simultaneously published in The Journal of the American Medical Association. The study results demonstrate that, when compared to standard coronary CT angiography (CT) alone, HeartFlow’s computed fractional flow reserve (FFRCT) coupled with coronary CT angiography provides a more accurate determination of which patients’ arterial blockages require invasive evaluation.